Providence Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.47M Buy
74,887
+21,675
+41% +$1M 0.64% 62
2025
Q1
$3.25M Buy
53,212
+732
+1% +$44.6K 0.67% 61
2024
Q4
$2.97M Buy
52,480
+221
+0.4% +$12.5K 0.6% 67
2024
Q3
$2.7M Buy
52,259
+276
+0.5% +$14.3K 0.54% 73
2024
Q2
$2.16M Buy
51,983
+797
+2% +$33.1K 0.47% 76
2024
Q1
$2.78M Buy
51,186
+14,645
+40% +$794K 0.61% 70
2023
Q4
$1.87M Sell
36,541
-1,643
-4% -$84.3K 0.45% 76
2023
Q3
$2.22M Buy
38,184
+902
+2% +$52.4K 0.58% 71
2023
Q2
$2.38M Buy
37,282
+626
+2% +$40K 0.6% 68
2023
Q1
$2.54M Buy
36,656
+674
+2% +$46.7K 0.67% 63
2022
Q4
$2.59M Sell
35,982
-37
-0.1% -$2.66K 0.7% 64
2022
Q3
$2.56M Buy
36,019
+629
+2% +$44.7K 0.77% 60
2022
Q2
$2.74M Buy
35,390
+1,355
+4% +$105K 0.8% 61
2022
Q1
$2.48M Buy
34,035
+2,389
+8% +$174K 0.61% 69
2021
Q4
$1.97M Buy
31,646
+1,462
+5% +$91.2K 0.54% 69
2021
Q3
$1.79M Buy
30,184
+2,142
+8% +$127K 0.56% 68
2021
Q2
$1.87M Buy
28,042
+2,594
+10% +$173K 0.61% 62
2021
Q1
$1.61M Buy
25,448
+1,577
+7% +$99.6K 0.58% 64
2020
Q4
$1.48M Buy
23,871
+4,071
+21% +$253K 0.61% 63
2020
Q3
$1.19M Buy
19,800
+439
+2% +$26.5K 0.63% 58
2020
Q2
$1.14M Buy
19,361
+19,261
+19,261% +$1.13M 0.65% 62
2020
Q1
$6K Hold
100
﹤0.01% 193
2019
Q4
$6K Hold
100
﹤0.01% 199
2019
Q3
$5K Sell
100
-54,300
-100% -$2.72M ﹤0.01% 192
2019
Q2
$2.47M Buy
54,400
+7,900
+17% +$358K 1.46% 32
2019
Q1
$2.22M Buy
46,500
+5,000
+12% +$239K 1.4% 30
2018
Q4
$2.16M Buy
41,500
+4,200
+11% +$218K 1.48% 17
2018
Q3
$2.32M Buy
37,300
+36,900
+9,225% +$2.29M 1.51% 19
2018
Q2
$22K Sell
400
-400
-50% -$22K 0.02% 151
2018
Q1
$51K Sell
800
-67
-8% -$4.27K 0.04% 118
2017
Q4
$53K Buy
+867
New +$53K 0.04% 117